111 related articles for article (PubMed ID: 7514553)
1. Monitoring serum tryptic activity and effect of trypsin inhibitor on rat acute pancreatitis.
Sobajima H; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sakai Y; Ishiguro H; Tanikawa M; Nakae Y
Digestion; 1994; 55(2):90-6. PubMed ID: 7514553
[TBL] [Abstract][Full Text] [Related]
2. Effect of a new synthetic trypsin inhibitor on taurocholate-induced acute pancreatitis in rats.
Sobajima H; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sakai Y; Ishiguro H; Tanikawa M; Nakae Y
Pancreas; 1993 Mar; 8(2):240-7. PubMed ID: 8460097
[TBL] [Abstract][Full Text] [Related]
3. Intracellular action of an exogenous low-molecular-weight synthetic protease inhibitor, E3123, in cerulein-induced acute pancreatitis in rats.
Sata N; Atomi Y; Kimura W; Kuroda A; Muto T; Mineo C
Int J Pancreatol; 1994 Apr; 15(2):119-27. PubMed ID: 8071570
[TBL] [Abstract][Full Text] [Related]
4. Combined therapy of a cephalosporin, Shiomarin and a new potent protease inhibitor, E3123 in rat taurocholate-induced pancreatitis.
Hirano T; Manabe T
Nihon Geka Hokan; 1992 Nov; 61(6):423-32. PubMed ID: 1306980
[TBL] [Abstract][Full Text] [Related]
5. Activation of trypsinogen in experimental models of acute pancreatitis in rats.
Nakae Y; Naruse S; Kitagawa M; Hirao S; Yamamoto R; Hayakawa T
Pancreas; 1995 Apr; 10(3):306-13. PubMed ID: 7542773
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of a cephalosporin, Shiomarin, plus a new potent protease inhibitor, E3123, on rat taurocholate-induced pancreatitis.
Hirano T; Manabe T; Imanishi K; Tobe T
J Gastroenterol Hepatol; 1993; 8(1):52-9. PubMed ID: 8439663
[TBL] [Abstract][Full Text] [Related]
7. Serum immunoreactive trypsin and trypsin inhibitors during acute pancreatitis.
Mero M; Tenhunen R; Pessi T; Sandholm M
Ann Chir Gynaecol; 1980; 69(6):251-5. PubMed ID: 6163388
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of prophylaxis with a protease inhibitor and a free radical scavenger against a temporary ischemia model of pancreatitis.
Hirano T; Furuyama H; Kawakami Y; Ando K; Tsuchitani T
Can J Surg; 1995 Jun; 38(3):241-8. PubMed ID: 7540502
[TBL] [Abstract][Full Text] [Related]
9. [Effects of E-3123, a new protease inhibitor, on several protease activities and on experimental acute pancreatitis].
Miyamoto K; Hishinuma I; Nagakawa J; Nagaoka N; Yamanaka T; Wakabayashi T
Nihon Yakurigaku Zasshi; 1988 May; 91(5):285-93. PubMed ID: 3410375
[TBL] [Abstract][Full Text] [Related]
10. Exacerbation of acute pancreatitis in the presence of chronic liver injury in rats, with special reference to therapeutic efficacy of prostaglandin E1.
Takahashi H; Imamura M; Mikami Y; Yamauchi H
Pancreas; 1999 Aug; 19(2):199-204. PubMed ID: 10438168
[TBL] [Abstract][Full Text] [Related]
11. On the role of the pancreatic secretory trypsin inhibitor as an inactivator of trypsin-alpha 2-macroglobulin complexes in acute pancreatitis.
Balldin G; Borgström A; Marks WH; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1984 Jul; 365(7):751-6. PubMed ID: 6207093
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats.
Iwaki M; Ino Y; Motoyoshi A; Ozeki M; Sato T; Kurumi M; Aoyama T
Jpn J Pharmacol; 1986 Jun; 41(2):155-62. PubMed ID: 2427760
[TBL] [Abstract][Full Text] [Related]
13. Prevention of experimental acute pancreatitis by intraduodenal trypsin inhibitor in rat.
Ono H; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sakai Y; Kiriyama S; Sobajima H
Dig Dis Sci; 1990 Jun; 35(6):787-92. PubMed ID: 2344814
[TBL] [Abstract][Full Text] [Related]
14. Effect of methylcarbonylmethyl 2(S)-[4-(4-guanidino-benzoyloxy)phenyl] propionate methanesulfonate (TT-S24) on experimental pancreatitis in rats.
Tagami H; Abe S; Yoshida Y; Tanaka I; Kamei C
Biol Pharm Bull; 1998 Mar; 21(3):227-30. PubMed ID: 9556150
[TBL] [Abstract][Full Text] [Related]
15. Effect of protease inhibitor FUT-175 on acute hemorrhagic pancreatitis in mice.
Suzuki M; Isaji S; Stanten R; Frey CF; Ruebner B
Int J Pancreatol; 1992 Feb; 11(1):59-65. PubMed ID: 1374785
[TBL] [Abstract][Full Text] [Related]
16. On the potential role of trypsin and trypsin inhibitors in acute pancreatitis.
Lasson A; Ohlsson K
Adv Exp Med Biol; 1984; 167():477-87. PubMed ID: 6201050
[TBL] [Abstract][Full Text] [Related]
17. Serum alpha 2-macroglobulin-trypsin complex and early recognition of severe acute pancreatitis after endoscopic retrograde pancreatography.
Nakae Y; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sakai Y; Sobajima H; Ishiguro H; Tanikawa M
J Gastroenterol Hepatol; 1994; 9(3):272-6. PubMed ID: 7519897
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of a prostaglandin E1 oligomer on taurocholate-induced rat pancreatitis.
Sakai Y; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sobajima H; Naruse S; Ohnishi ST
J Gastroenterol Hepatol; 1992; 7(6):591-5. PubMed ID: 1486188
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological studies of FUT-175, nafamstat mesilate. II. Effects on experimental acute pancreatitis].
Iwaki M; Ozeki M; Sato T; Suzuki K; Motoyoshi A; Suzuki S; Fujita M; Aoyama T
Nihon Yakurigaku Zasshi; 1984 Oct; 84(4):363-72. PubMed ID: 6210233
[TBL] [Abstract][Full Text] [Related]
20. Local administration of human pancreatic secretory trypsin inhibitor prevents the development of experimental acute pancreatitis in rats and dogs.
Ohlsson K; Olsson R; Björk P; Balldin G; Borgström A; Lasson A; Kohno T; Thompson RC
Scand J Gastroenterol; 1989 Aug; 24(6):693-704. PubMed ID: 2814337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
